Search

Your search keyword '"Dietzen M"' showing total 39 results

Search Constraints

Start Over You searched for: Author "Dietzen M" Remove constraint Author: "Dietzen M"
39 results on '"Dietzen M"'

Search Results

1. Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling

2. The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma

3. Replication timing alterations are associated with mutation acquisition during breast and lung cancer evolution

5. Body composition and lung cancer-associated cachexia in TRACERx

6. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

7. Genomic–transcriptomic evolution in lung cancer and metastasis

8. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA

9. Antibodies against endogenous retroviruses promote lung cancer immunotherapy

10. The evolution of lung cancer and impact of subclonal selection in TRACERx

11. Copy number architectures define treatment-mediated selection of lethal prostate cancer clones

12. The evolution of lung cancer and impact of subclonal selection in TRACERx

15. MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically

16. Modellierung von Protein-Interaktionen in Protein-Bindetaschen und oligomerischen Protein-Komplexen

17. The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program “CASCADE”

18. The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program 'CASCADE'

19. Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution

20. Replication timing alterations are associated with mutation acquisition during breast and lung cancer evolution.

21. Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx.

22. The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.

23. The evolution of non-small cell lung cancer metastases in TRACERx.

24. The evolution of lung cancer and impact of subclonal selection in TRACERx.

25. Genomic-transcriptomic evolution in lung cancer and metastasis.

26. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx.

27. The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner.

28. Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution.

29. SnapShot: Tumor evolution.

30. Pervasive chromosomal instability and karyotype order in tumour evolution.

31. MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically.

32. Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution.

34. The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".

35. DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.

36. Large oligomeric complex structures can be computationally assembled by efficiently combining docked interfaces.

37. Efficient computation of root mean square deviations under rigid transformations.

38. On the applicability of elastic network normal modes in small-molecule docking.

39. Identification of CYP106A2 as a regioselective allylic bacterial diterpene hydroxylase.

Catalog

Books, media, physical & digital resources